Lysophosphatidic acid (LPA) Hypoxia inducible factor 1a (HIF-1a) Neuronal development Conditional knock out mouse Autotaxin (ATX) is a secreted glycoprotein widely present in biological fluids, originally isolated from the supernatant of melanoma cells as an autocrine motility stimulation factor. Its enzymatic product, lysophosphatidic acid (LPA), is a phospholipid mediator that evokes growth-factor-like responses in almost all cell types through G-protein coupled receptors. To assess the role of ATX and LPA signalling in pathophysiology, a conditional knockout mouse was created. Ubiquitous, obligatory deletion resulted to embryonic lethality most likely due to aberrant vascular branching morphogenesis and chorio-allantoic fusion. Moreover, the observed phenotype was shown to be entirely depended on embryonic, but not extraembryonic or maternal ATX expression. In addition, E9.5 ATX null mutants exhibited a failure of neural tube closure, most likely independent of the circulatory failure, which correlated with decreased cell proliferation and increased cell death. More importantly, neurite outgrowth in embryo explants was severely compromised in mutant embryos but could be rescued upon the addition of LPA, thus confirming a role for ATX and LPA signalling in the development of the nervous system. Finally, expression profiling of mutant embryos revealed attenuated embryonic expression of HIF-1a in the absence of ATX, suggesting a novel effector pathway of ATX/LPA.
Autotaxin (ATX, ENPP2) is a secreted glycoprotein widely present in biological fluids, including blood, cancer ascites, synovial fluid and cerebrospinal fluid (CBF), originally isolated from the supernatant of melanoma cells as an autocrine motility stimulation factor (Stracke et al., 1992) . Increased ATX expression has been detected in a large number of malignancies, including mammary, thyroid, hepatocellular and renal cell carcinomas, non-small-cell lung cancer, as well as glioblastoma and neuroblastoma (Umezu-Goto et al., 2004; van Meeteren and Moolenaar, 2007) .
ATX is encoded by a single gene on human chromosome 8 (mouse chromosome 15) whose transcription, regulated by diverse transcription factors (Hoxa13, NFAT-1 and v-jun), results in three alternatively spliced isoforms (α, β and γ) (Giganti et al., 2008; van Meeteren and Moolenaar, 2007) . ATX is synthesized as a preproenzyme, secreted into the extracellular space after the proteolytic removal of its N-terminal signal peptide . ATX is a member of the ectonucleotide pyrophosphatase/phosphodiesterase family of ectoenzymes (E-NPP) that hydrolyze phosphodiesterase (PDE) bonds of various nucleotides and derivatives . More importantly, ATX has been identified as the long elusive plasma lysophospholipase D (lysoPLD), an enzyme that mainly catalyzes the conversion of lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA) (Tokumura et al., 2002; Umezu-Goto et al., 2002) .
LPA is produced in various conditions both in cells and in biological fluids and is a major constituent of serum, tightly bound to albumin and gelsolin (Aoki, 2004; van Meeteren and Moolenaar, 2007) . LPA is a phospholipid mediator that evokes growth-factor-like responses in almost all cell types, including cell growth, survival, differentiation and motility (Luquain et al., 2003; Mills and Moolenaar, 2003; Moolenaar et al., 2004) . The large variety of LPA effector functions is attributed to at least six, G-protein coupled, LPA receptors with overlapping specificities and wide spread distribution (Choi et al., 2008; Ishii et al., 2009 ). Phospholipid homeostasis has been shown to affect various pathological conditions and cellular pathways, thus attracting increased diagnostic and pharmacological interest (Fuchs and Schiller, 2009 ).
ATX expression is first detected at the floor plate of the neural tube, as well as in the choroid plexus of the embryonic brain (van Meeteren and Moolenaar, 2007) , which was shown to be an essential organizing center for inducing dorsal neuron fates and sustaining neuron function (Awatramani et al., 2003) and was identified as a possible location of stem/progenitor cells (Li et al., 2002) . In the post-natal CNS, ATX is expressed in secretory epithelial cells, such as the choroid plexus, ciliary, iris pigment, and retinal pigment epithelial cells, whereas there is evidence for ATX expression in leptomeningeal cells and cells of the CNS vasculature (van Meeteren and Moolenaar, 2007) . ATX was found upregulated during oligodendrocyte maturation, temporally correlated with the process of myelination (Dugas et al., 2006; Fox et al., 2003; Fuss et al., 1997) , while significant ATX expression was detected in the CBF of multiple sclerosis patients (Hammack et al., 2004) . Increased ATX expression was also detected in activated astrocytes following brain lesion (Savaskan et al., 2007) , as well as in the frontal cortex of Alzheimer-type dementia patients (Umemura et al., 2006) .
High levels of LPA have been demonstrated in the brain, shown to affect most neural cell types, impacting axonal and dendritic morphology, neuronal apoptosis, neural precursor cell survival, process retraction in oligodendrocyte precursors, hypertrophy of astrocytes and microglial activation and migration (Fukushima, 2004; Fukushima et al., 2002) . Furthermore, LPA levels are increased during pathological conditions of the brain, such as in response to injury, cerebral ischemia, and following disruption of the blood-brain barrier (Fukushima, 2004; Fukushima et al., 2002) . In accordance, LPA receptors are enriched in the CNS and their expression patterns suggest their potential involvement in developmental process including neurogenesis, neuronal migration, axon extension and myelination (Ishii et al., 2004) .
In the present study we report the creation of a novel conditional (LoxP) knock out mouse for ATX (exons 1-2; C57BL/6 genetic background). As previously reported (Koike et al., 2009; Tanaka et al., 2006; van Meeteren et al., 2006) , ubiquitous deletion of ATX resulted to embryonic lethality most likely due to aberrant vascular branching morphogenesis and chorio-allantoic fusion. Moreover, the observed phenotype was shown to be entirely dependent on embryonic, but not maternal or extraembryonic, ATX expression. In addition and through the use of a neuronal reporter transgene, we have shown that ATX null mutants exhibited failure of neural tube closure correlating with decreased cell proliferation and increased cell death, while LPA was shown to rescue growth and neurite outgrowth in embryonic explants. Expression profiling of mutant embryos revealed a large number of deregulated genes and pathways; among them the expression of hypoxia-inducible factor 1-a (HIF-1a) was found severely downregulated and shown to be dependent on LPA signalling.
Materials and methods

Mice
All mouse strains used were maintained on a C57BL/6 genetic background at the animal facilities of the Biomedical Sciences Research Institute "Alexander Fleming" under specific pathogen free conditions, in compliance with the Declaration of Helsinki principles. Mice were housed at 20-22°C, 55 ± 5% humidity, and a 12 h light-dark cycle; food and water was given ad libitum. All experimentation was approved by an internal Institutional Review Board, as well as by the Veterinary service and Fishery Department of the local governmental prefecture. The generation of CMV-Cre, Sox2-Cre and Tie1-Cre transgenic mouse lines have been reported previously (Gustafsson et al., 2001; Hayashi et al., 2002; Schwenk et al., 1995) .
Generation of an Enpp2 targeting vector
For the construction of an Enpp2 targeting vector (Fig. 1A) , a C57BL/6 BAC clone (RPCI-216A) encompassing the Enpp2 gene was obtained and PCR primers with appropriate restriction sites at their termini were designed for the amplification of a 5-Kb 5′ flanking fragment (left homology arm, LA), a 1.2-Kb central fragment (containing exons 1 and 2 of the Enpp2 gene, central homology arm, CA) and a 4-Kb 3′ flanking fragment (right homology arm, RA), respectively. After PCR amplification with a proofreading polymerase (Pfu Turbo, Stratagene, CA, USA), each fragment was subcloned into pBluescript KSM plasmid, using the restriction sites attached to the termini of PCR primers. CA was excised (as a NotI-SalI fragment) from pBluescript KSM and introduced in the pEasyFlox targeting vector, followed by subcloning of RA (as a RhoI fragment) and LA (as NotI fragment). Primer sequences (5′ to 3′) were as follows: LA-F: GCG GCC GCG AGA TGT CAC ATA CTC TTT; LA-R: AGT ATG AGA AAC AGA CA; CA-F: TCT AGA CAG AAG GGC TTT ATG CAG CT; CA-R: GTC GAC TAA ATG TAT CGC CCT GCA CA; RA-F: CCC AAG GTG AGA ATA GGT TA; RA-R: CTC GAG CGT ACA TTA TGC TCA GTG GC.
Following proofreading with sequencing of all restriction sites and the entire CA (containing exons 1-2), the targeting construct was linearized with SfiI and electroporated into Bruce-4 (C57BL/6) embryonic stem (ES) cells. After positive selection with neomycin, southern blot analysis of EcoRV-digested DNA (Fig. 1B ) from 192 drug-resistant clones with a 5′ flanking external probe (P1), yielded 23 correctly targeted clones (12%). The integrity of the construct was verified with southern blot analysis of BamHI-digested ES DNA with a 3′ external probe (Fig. 1A P2 , data not shown).
Genomic DNA isolation and Southern blot DNA was isolated by Proteinase K digestion (10 μg/ml, Roche Diagnostics, Mannheim, Germany) of tail snips and ethanol precipitation. DNA samples (10 μg) were digested with EcoRV and separated by agarose gel electrophoresis (0,8% in TAE buffer). Following transfer of DNA into positively charged nylon transfer membrane (Hybond-N + , Amersham Pharmacia Biotech Ltd., Little Chalfont, Buckinghamshire, UK) hybridization with radiolabelled probe P1 was performed at 65°C in Hybuffer (7% SDS, 10% PEG, 1,5× SSPE, 100 μg/ml salmon sperm).
PCR Genotyping of targeted ES cells and conditional Enpp2
n/n mice To be able to identify all Cre-mediated recombination events 5 primers were designed (A1, B1, C1, A2 and B2; Fig. 1A ). Primer sequences were as follows (5′ to 3′): A1: CGC ATT TGA CAG GAA TTC TT; B1: ATT TGT CAC GTC CTG CAC GA; C1: ATC AAA ATA CTG GGG CTG CC; A2: CGA ATC TCT CCG ATC ACT AC; B2: TAC ACA ACA CAG CCG TCT CA. Primer set A1/C1 yields a PCR product of 223 bp corresponding to the wild type (WT) alleles. Primer set A1/B1 yields a PCR product of 456 bp corresponding to the floxed (neo) allele. Detection of the recombined allele is achieved by primer set A1/B2 that yields a PCR product of 422 bp. Primer set A2/B2 yields 552 and 459 bp products for the floxed (neo) and wt alleles respectively. Use of primer set A2/ B2 confirms the presence or absence of Loxp3 thus verifying that Cremediated recombination resulted in the efficient excision of exons 1-2 that are flanked by LoxP2-P3 (and not in the excision of sequences flanked by LoxP1-2).
All PCRs were performed with 50-100 ng DNA, 0.125-0.250 mM dNTPs, 0.25-0.5 pmol of each primer, a custom made Taq DNA polymerase and 1.5 mM MgCl 2 for 1 cycle at 94°C for 3 min, 25-30 cycles of 94°C for 2 min, 58°C for 1 min, 72°C for 1 min and 1 cycle of 72°C for 3 min.
Serum/plasma isolation
Blood was collected from mouse tail vein and incubated at 4°C for 10 min. Serum was obtained by centrifugation at 6000 rpm for 8 min and at 12000 rpm for 8 min at 4°C and stored at − 80°C. For plasma isolation, blood was collected in 50 mM EDTA, centrifuged at 12000 rpm for 8 min at 4°C and stored in siliconized tubes at -80°C.
ATX ELISA
To detect ATX in biological fluids, a direct ELISA assay was developed using the commercially available anti-phospholipase D polyclonal antibody (Cat. No. 10005375, Cayman chemical, USA) . The bottom of a NUNC-IMMUNO 96 MicroWell Elisa plate was coated overnight with 100 μl of 1:200 diluted serum in 0.05 M carbonate/ bicarbonate coating buffer, pH 9.5 (Cat. No. S7795/S7277, Sigma, Saint Louis, MI, USA), washed three times with 0.05% Tween-20 (Cat. No. P1379, Sigma, USA) in TBS and blocked with 0.1% Bovine Serum Albumin (Cat. No. A7888, Sigma, USA) in 0.05% TBST for 1 h at RT. For each ELISA assay, 100 μl of two-fold serial dilutions of recombinant ATX protein ranging from 0.1 to 1.6 μg/ml were plated as standard curve and treated as all samples. The plate was then incubated with 0.5 μg/ml detection antibody for 1 h and washed three times with 0.05% TBST. Autotaxin antigen was then detected with an anti-rabbit HRP-labeled secondary antibody (Cat. No. 4010-05, SouthernBiotech, USA) that was developed with TMB substrate (Cat. No. A7888, Sigma, USA). Readings were obtained at 450 nm. All samples and standards were assayed in triplicates.
ATX activity assay
Autotaxin activity in plasma of mice was determined using the cleavage of the ATX-specific fluorogenic substrate FS-3 (Echelon Biosciences, UT, USA). Assays were conducted in a final volume of 100 μl comprising 20 μl 5 × assay buffer (700 mM NaCl, 25 mM KCl, 5 mM MgCl 2 and 250 mM Tris, pH 8.0), 20 μl of FS-3 (final concentration 2.5 μM) and 60 μl of plasma (diluted 1:5 in 1 × PBS). Reactions were incubated at 37°C in a Tecan Infinite 200 microplate reader (Tecan Trading AG, Switzerland) set to make fluorescence measurements every 5 min for 1 h. Autotaxin activity was quantitied by measuring the rate of fluorescence increase at 528 nm with excitation at 485 nm.
LC/MS
Lipids were extracted as previously described (Xiao et al., 2001) . Mass spectrometry analyses were performed using API-4000 (Applied Biosystems/MDS SCIEX). Samples (10 μl) were loaded through a LC system (Agilent 1100) with an auto sampler. The mobile phase was MeOH/water/NH4OH (90:10:0.1, v/v/v). A TARGA C18 5 μm, 20 × 2.1 mm TR-0221-C185 (Higgins Analytical, Southborough, MA USA) HPLC column was used for the separation of different lipids and for the detection of LPA and S1P. The HPLC conditions were 12 min/ sample using the following three-phase flow rate scheme: 1) increasing flow rate from 0.2 to 0.5 ml/min for the first 5 min; 2) constant flow rate of 0.5 ml/min for 5 min and 3) decreasing flow rate from 0.5 to 0.2 ml/min for 2 min. Standard curves were established for quantitative analysis as previously described (Xiao et al., 2001) .
Embryo histopathology
For histopathology, embryos were fixed in 10% formalin O/N at 4°C. 4 μM thick embryo sections were stained with Hematoxylin/ Eosin and visualized under a Nikon ECLIPSE E800 microscope (Nikon Corp., Shinagawa-ku, Tokyo, Japan).
For immunohistochemistry, embryos were fixed in 4% paraformaldehyde for 2 h at RT. After three washes in PBS (15 min), embryos were incubated in 30% sucrose for 12 h at 4°C followed by embedding in OCT (BDH, Poole, UK) and storage at −70°C. 7-μm thick serial embryo cryosections were immunostained with primary antibodies against Shh, AP2a, Pax3, Islet1, Pax6 (1:100; Developmental Studies hybridoma bank, University of Iowa, Iowa, USA) Sox2 (Chemicon/ Millipore, Billerica, MA, USA) and Sox10 (Abcam Inc, Cambridge, MA, USA). Mitotic cells were labeled with anti-phospho histone H3 antibody (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA) O/N at 4°C. Neurite outgrowth was monitored with immunostaining of TuJ1, a neuronal differentiation marker (1:500, Covance, Richmond, CA, USA). Following incubation with the appropriate secondary antibodies conjugated to Alexa fluorophore 488 or 555 (1:500, Molecular Probes/Invitrogen, Carlsbad, CA, USA) for 1 h at RT, sections were mounted and observed under a fluorescent microscope (Nikon Corp., Shinagawa-ku, Tokyo, Japan).
For X-Gal staining, embryos were fixed in 0.2% glutaraldehyde, 2% formaldehyde at 4°C for 10 min, followed by three washes in Lo buffer (100 mM PB, 2 mM MgCl2, 5 mM EGTA) for 5 min each. Embryos were then stained in X-gal staining solution (100 mM PB, 2 mM MgCl2, 5 mM EGTA, 0.01% deoxycolic acid, 0.02% IGEPAL, 500 mM potassium ferricyanide, 500 mM potassium ferrocyanide, 1 mg/ml X-gal) at 37°C until the desired color intensity was reached (several hours to O/N). After staining, embryos were washed three times for 5 min each in PBS buffer, refixed with 4% paraformaldehyde at 4°C for 30 min to O/N and then dehydrated through a methanol gradient mounted and observed under light microscope.
For the TUNEL assay, 5-μm thick OCT-embedded embryo cryosections were used for in situ labelling of apoptotic cells (TUNEL assay) using the terminal deoxynucleotidyl transferase enzyme (TdT) (In situ cell death detection kit (AP), Roche Diagnostics GmbH, Mannheim, Germany). Sections were mounted on coverslips and evaluated by light microscopy. Negative (omission of TdT) and positive (sections treated with DNaseI) controls were included in all analyses.
For the in situ hybridization, embryos were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer at 4°C for 2 h. They were then dehydrated through a methanol gradient and stored in 100% methanol at −20°C. For hybridization Patch1 cDNA was used in vector pBS KS which allowed the generation of antisense probe by in vitro transcription using a linearized vector and the T7-RNA-polymerase.
Embryo explants culture and embryo histopathology E8.5 embryos were dissected in DMEM F:12 supplemented with 2 mM Glutamine, penicillin and streptomycin (all from Gibco-Life Technologies-Invitrogen, Carlsbad, CA, USA). The somitic part of the trunk was dissected and placed on matrigel support in the presence of DMEM F:12 medium supplemented with 10% FCS, 15% chicken embryo extract (SLI, Bolney, West Sussex, UK), 2 mM glutamine, 20 ng/ml bFGF and Penicillin-Streptomycin (10 U/ml-100 μg/ml; Gibco-Life Technologies-Invitrogen). Explants were cultured at 37°C, 5% CO 2 for 48 h. For the rescue experiments, media were supplemented with 10 μM LPA (Avanti, polar lipids, Alabaster, AL, USA).
RNA extraction, microarray hybridizations and data analysis
RNAs from E9.5 embryos were purified with Trizol (Invitrogen Ltd, Paisley, PA4 9RF, UK), followed by a single passage from RNeasy columns (QIAGEN GmbH, Hilden, Germany) according to manufacturers' instructions. RNA integrity was assessed on Agilent's Bionalyzer and 0.2 μg of total RNA was used to generate biotinylated complementary RNA (cRNA), according to the "Two-Cycle Target Labeling" protocol (GeneChip® Expression Analysis Technical Manual; Affymetrix, Santa Clara, CA 95051, USA; Revision 510). Fragmented cRNA samples were then hybridized onto the Affymetrix MOE430 2.0 GeneChip expression arrays (following testing on Affymetrix Test3 arrays). Hybridization quality controls were performed using the Affymetrix GeneChip Operating System (GCOS) and data quality control analysis was performed in R-Bioconductor v2.3.1 and in Partek Genomics suite software ver6.3 (Partek Incorporated, St. Louis, MO, USA). Following quality controls, gcRMA quantile normalization was conducted on the data using R-Bioconductor v2.3.1. ANOVA statistics was performed on Partek Genomics suite. The complete, MIAMEcompliant (Brazma et al., 2001 ) data set (both raw and normalized) is publicly available (#E-MEXP-1881) at ArrayExpress (Parkinson et al., 2007) .
Results
Generation of a conditional knockout Enpp2 mouse allele
To assess the role of ATX in pathophysiology through the inactivation of its expression in a cell/tissue specific manner, we created an ATX conditional knockout allele. LoxP sites were genetically engineered to flank the first two exons of the Enpp2 gene (Fig. 1A) and thus completely abolish any expression from the Enpp2 locus upon cell/tissue specific Cre expression and subsequent Cre-mediated recombination. A neomycin floxed cassette was also inserted immediately upstream of floxed exons to be used as a positive selection marker of targeted embryonic stem cells (ES; C57BL/6). ES clones carrying the genetically modified Enpp2 allele (Enpp2 n ; Fig. 1B) were injected into C57BL/6 blastocysts, which were then implanted into foster mothers. Chimeric offspring were mated to C57BL/6 mice and the F1 generation was screened for germ line transmission of the targeted allele by southern blot (data not shown) and PCR analysis (Fig. 1C) . Enpp2 n/n mice (obtained with intercrossing of heterozygous Enpp2 n/+ mice) were found correctly targeted and exhibited no phenotypic or breeding anomalies.
Ubiquitous, germ line ablation of Enpp2 results to embryonic lethality
To induce ubiquitous, germ line inactivation of the Enpp2 gene, Enpp2 n/n mice were crossed with a transgenic mouse strain expressing the Cre recombinase driven by the CMV promoter (Schwenk et al., 1995) . Offspring heterozygous null mutant mice (Enpp2 +/− ) were found properly recombined (Fig. 1C ) and exhibited no phenotypic or breeding anomalies. However, recombinant Enpp2 +/− mice produced almost 50% less ATX in their serum, as detected with ELISA (Fig. 1D) . Concomitantly, ATX activity, as detected through the hydrolysis of its fluorogenic substrate FS-3 (Ferguson et al., 2006) , was also found 50% decreased (Fig. 1E) . In turn, LPA levels in their plasma were also found decreased by 50% (Fig. 1F ). No differences in serum LPA levels were detected (Enpp2 +/+ 1.9 μΜ ± 0.1; Enpp2 −/− 2.0 μΜ ± 0.1; as assayed with a radioenzymatic assay (Saulnier-Blache et al., 2000) ), due to platelet activation and subsequent LPA release as previously reported (van Meeteren and Moolenaar, 2007; van Meeteren et al., 2006) . Intercrossing of heterozygous Enpp2 +/− mice produced no homozygous Enpp2 −/− offspring among 100 newborn mice (P0; Table 1 ), indicating that genetic deletion of ATX results to embryonic lethality (Tanaka et al., 2006; van Meeteren et al., 2006) . To identify the lethal embryonic stage, embryos from heterozygous Enpp2
intercrosses were isolated at different embryonic days post coitum (E) and PCR genotyped from their respective yolk sacs (Fig. 1C) . Normal mendelian ratios (Table 1) were observed at E8.5 and E9.5 (albeit with severe malformations as described below), while at E10.5 a large number of knockout embryos had been resorbed while the remaining ones appeared necrotic (Tanaka et al., 2006; van Meeteren et al., 2006) . Therefore Enpp2 −/− mutant embryos die soon after E9.5, the developmental point that ATX expression is first detected at the floor plate of the neural tube (Bachner et al., 1999) . To examine if the observed embryonic lethality could be attributed to the reduced maternal levels of ATX and LPA (Enpp2 +/− ; Figs. 1D-F), embryos from Enpp2 +/− intercrosses were transferred to wild type surrogate mothers. No differences were observed in embryonic lethality or embryonic phenotypes (data not shown), indicating that the observed embryonic phenotype was not due to the reduced maternal levels of ATX and LPA. Moreover and in order to exclude possible extraembryonic effects in the absence of ATX, we have utilized a transgenic mouse strain expressing the Cre recombinase driven by the Sox2 promoter. Paternal Sox2Cre transgene transmission induces recombination in all epiblast cells but little or no activity in extraembryonic cell types and tissues, such as the yolk sac (Hayashi et al., 2002; Vincent and Robertson, 2003) . On the contrary, when the Sox2Cre is contributed maternally recombination occurs in both embryonic and extraembryonic tissues (Hayashi et al., 2002; Vincent and Robertson, 2003) . As it can be seen at Table 2 , no Enpp2 n/n Sox2Cre +/− mice could be detected among offspring, irrespectively of the Sox2Cre transmission. Moreover, Sox2-driven, Cre-mediated ATX ablation resulted in identical embryonic lethal phenotypes with the CMV-driven ones (data not shown). Therefore embryonic only ATX deletion (with parental Sox2Cre transgene transmission) is, most likely, sufficient for the observed phenotype and lethality.
Circulatory failure in Enpp2
−/− embryos At E8.5, Enpp2 −/− embryos exhibited normal growth (and somitic pairs) and gross patterning of embryonic structures (Figs. 2A, B) (van Meeteren et al., 2006) . However and in 50% of mutant embryos analyzed, there was abnormal development of the allantois which appeared swollen and failed to fuse to the chorion (Fig. 2C ) (Tanaka et al., 2006; van Meeteren et al., 2006) . Of note, all mutant embryos appeared phenotypically similar irrespective of their allantoic fusion. At E9.5, Enpp2 −/− embryos (that expressed no ATX protein; Fig. 1G) failed to initiate axial turning and exhibited retarded overall growth (and reduced somitic pairs) (Figs. 2A and 3A) (Tanaka et al., 2006; van Meeteren et al., 2006) . Enpp2 −/− yolk sacs presented with aberrant vascular branching morphogenesis (Fig. 2D) , despite adequate development of vessels (which furthermore appeared enlarged) (van Meeteren et al., 2006) . Erythrocytes appeared normal but trophoblast giant cells and chorionic plate cells showed signs of degeneration and the allantoic blood vessels failed to spread into the decidual zone (Fig. 3A ) (Tanaka et al., 2006) . Enlarged vessels were also observed in the cephalic region of Enpp2 −/− embryos (Fig. 2B) ; the heart could still beat at E9.5 Enpp2 −/− embryos (albeit nonrhythmically; videos not shown). The apparent circulatory failure of Enpp2 −/− embryos was not due to reduced levels of VEGF or VEGFR2
(as detected with immunostaining; Figs. 3B and C respectively) or any apparent endothelial or smooth muscle differentiation defect as detected with CD31/PECAM-1 (data not shown and ( van Meeteren et al., 2006) ) and smooth muscle actin/SMA staining (Fig. 3D) . Moreover, ATX deletion specifically in the endothelium (driven by the Tie1 promoter) (Gustafsson et al., 2001) did not lead to embryonic lethality (Table 2) or any developmental defects (data not shown).
ATX and LPA signaling are necessary for the development of the nervous system
The most striking developmental defect of E9.5 Enpp2 −/− embryos was the failure of neural tube closure (Fig. 2B) . The development of the neural tube in Enpp2 −/− mice was further monitored with the use of the reporter gene Sox1bgeo (that expresses specifically in the neural system and is detected by lacZ staining) (Ekonomou et al., 2005) . Phenotypic analysis of E9.5 Enpp2 −/− /Sox1bgeo +/− embryos confirmed the failure of neural tube closure and the asymmetric headfolds in the absence of ATX and indicated a kinky neural tube along the anterior-posterior axis (Figs. 4A and B) . Embryonic growth and development (including neural tube closure and neuronal development) are dependent on cell migration, regional differences in mitotic rate, and specific sites and rates of programmed cell death. As LPA has been reported to modulate each of these processes in various cell types in vitro (van Meeteren and Moolenaar, 2007) , we next analyzed proliferation (through staining of the mitotic marker phospho histone H3; PH3) and cell death (TUNEL assay) at E9. (Figs. 4D, F) . To identify if the failure of neural tube development could be due to aberrant dorsal-ventral (D-V) patterning, we next examined the sonic hedgehog (Shh) signalling pathway, the master regulator of D-V patterning and neural plate bending, also implicated in neural cell proliferation and survival (Cohen, 2003; Ho and Scott, 2002) . However no differences in the expression of Shh (and its receptor Ptch1) were observed at Enpp2 −/− E9.5 embryos (Fig. 5) . Similarly no significant changes were observed in the expression pattern of various bona fide D-V patterning genes (Sox2, Sox10, Ap2a, Pax3, Pax6 and Islet1) (Fig. 5) . Therefore, aberrant neural tube development in the absence of ATX/LPA is not due to deregulated Shh signalling and D-V patterning, but most likely due to the absence of LPA signalling. To further explore a role for ATX/LPA in neuronal differentiation and growth, we isolated and cultured the somitic part of the embryo trunk from E8.5 embryos (6-8 somites) as described in Materials and methods. After 2 days in culture, Enpp2 −/− explants grew to only half the size of their wt littermates (Fig. 6 ), in analogy with embryo size in utero. Moreover, neurite outgrowth, as detected with TUJ1 staining, was found severely compromised in the absence of ATX (Fig. 6 ). Both embryo explant size and neurite outgrowth were restored to wt levels upon the addition of LPA, strongly suggesting that the role of ATX in the development of the nervous system is mainly mediated by its enzymatic product, LPA.
Expression profiling of Enpp2 −/− embryos
To explore systematically changes in gene expression in the absence of ATX, total RNA from E9.5 Enpp2 −/− embryos and wt littermates were hybridized (in triplicates) to Affymetrix DNA oligonucleotide microarrays interrogating the expression of 45,101 probesets corresponding to over 39,000 genes. Following quality controls, normalization and statistical analysis, 499 differentially expressed genes (DEGs) were identified with statistical significant changes in their expression in the absence of ATX/LPA (p b 0.05; False Discovery Rate (FDR) b 0.05; Fold Change (FC)N2; Supplemental Table S1 ). Moreover, to infer deregulated biological processes and molecular functions from the gene expression data, as these are encoded in the Gene Ontology (GO) (Ashburner et al., 2000) terms assigned to each known gene, we analyzed GO term frequencies in the selected 499 DEGs list. The statistical significant (p b 0.05) deregulated processes and functions (Supplemental Table S2 ) include a number of well expected, basal perturbations (in transcription, translation and different enzymatic activities) and a number of perturbations essentially describing the apparent phenotype of Enpp2 −/− embryos (cell cycle, cell differentiation, patterning of blood vessels, placental development, neurogenesis, muscle contraction).
ATX and LPA are necessary for embryonic HIF-1a expression
Remarkably, among the most statistical significant and differentially expressed genes in the absence of ATX/LPA (Supplemental Table  S1 ), was Hif-1a, a subunit of the transcription factor HIF, the key mediator of cellular responses to hypoxia (Semenza, 2007; Weidemann and Johnson, 2008) . To validate the results, transverse sections from Enpp2 −/− embryos and wt littermates were immunostained for HIF-1a. In wt embryos HIF-1a expression was localized at the marginal layers of the neural tube and cephalic and intersomitic mesenchyme (Fig. 7A) , as previously described (Lee et al., 2001) . No HIF-1a could be detected at the mutant embryos (Fig. 7A) , while no major differences were observed in the expression pattern of HIF-2a (data not shown).
The lack of HIF-1a expression in the absence of ATX/LPA was correlated with the absence of Akt (Akt1/2/3 Fig. 7B ), a positive regulator of HIF-1 (Bardos and Ashcroft, 2005 ) that has been suggested to mediate LPA-induced cell migration (Kim et al., 2008) . Given the circulatory abnormalities of the mutant mice and in order to examine if HIF-1a expression could reflect possible differences in O2 tension, wt and Enpp2 −/− E9.5 embryos were double-immuno-labeled for HIF-1a and for the hypoxia marker pimonidazole (Lee et al., 2001) . As previously described (Lee et al., 2001) , in wt E9.5 embryos HIF-1a expression and hypoxic regions were spatiotemporally colocalized (Fig. 7C) . No major differences in the hypoxic pattern were observed at Enpp2 −/− embryos that albeit completely lacked HIF-1a expression (Fig. 7C ). Moreover and as the absence of embryonic HIF-1a expression has been previously correlated with mesenchymal cell death (Kotch et al., 1999) , also observed in the absence of ATX/LPA (Fig. 4C ), wt and Enpp2 −/− E9.5 embryos were double-immuno-labeled for HIF-1a and TUNEL + cells.
As shown in Fig. 7C , cell death was observed in regions of Enpp2
−/− embryos that should have been expressing HIF-1a. More importantly, HIF-1a immunostaining of somatic trunk explants sections indicated that LPA was able not only to restore embryo size and neurite outgrowth (Fig. 6 ) but both Akt and HIF-1a expression in ATX null explants (Figs. 7B, C).
Discussion
As shown in this report, genetic deletion of ATX (through conditional floxing of exons 1-2 and ubiquitous cre mediated recombination; Figs. 1A-C) resulted to embryonic lethality soon after E9.5 (Table 1) . Analysis of the lethal embryonic phenotype in the absence of ATX revealed retarded growth (Figs. 2A, B) , severe circulatory problems (Figs. 2C, D, 3A) and neural tube defects (Figs. 2B and 4A, B) . Identical results were obtained in two previous efforts, despite deletion of different exons, conditional or straight genetic targeting and different genetic backgrounds (Koike et al., 2009; Tanaka et al., 2006; van Meeteren et al., 2006) . Similar embryonic lethality was also obtained with a targeted point mutation at the catalytic center of ATX (Ferry et al., 2007) , which completely blocks ATX's lysoPLD and PDE activities (van Meeteren and Moolenaar, 2007) . Moreover and as shown here, the observed embryonic phenotype was found completely independent of maternal or extraembryonic levels of ATX. Therefore, ATX expression at the developing embryo and ATX-mediated LPA production and subsequent G-protein coupled receptor (GPCR) signalling are essential for vascular branching morphogenesis and chorio-allantoic fusion, which seem to be the primary causes of embryonic death in the absence of ATX. However, genetic deletion of ATX specifically from endothelial cells did not produce any appreciable defect, thus excluding an autocrine role for ATX in endothelial differentiation. Similar defects in the vascular system as the ones observed at the Enpp2 −/− embryos have been also reported for Gα13 −/− embryos (Offermanns et al., 1997) . Gα13 is a ubiquitously expressed subunit of heterotrimeric G-protein complexes that act as molecular switches in signal transduction pathways mediated by GPCRs (Oldham and Hamm, 2008) , such as the LPA ones (Moolenaar et al., 2004) . Remarkably, Gα13 was discovered severely downregulated in Enpp2 −/− embryos (Supplemental Table S1 ), suggesting that the vascular defects in the absence of ATX/LPA were possibly due to the lack of Gα13-mediated signal transduction. As Gα13 −/− embryos exhibited no defect in neural tube development, it seems that the neural tube defects observed at the Enpp2 −/− embryos are independent of the circulatory failure. In accordance, ATX is first expressed at the floor plate of the neural tube at E9.5 (Fig. 1G ) (Bachner et al., 1999) , following the expression (E8.5) of most LPA receptors at neural headfolds, forebrain and hindbrain (Ohuchi et al., 2008) . As shown here, ATX expression was found necessary for proper neural tube development and closure (Figs. 4A,  B) , correlating with decreased proliferation and increased apoptosis (Figs. 4C, D) , consistent with (most of) the responses of neural cell lineages to LPA in vitro (Fukushima, 2004; Fukushima et al., 2002; Ishii et al., 2004) . More importantly, LPA could restore size and neurite outgrowth in ATX deficient embryo explants (at 10 μΜ- Fig. 6 , as well as with 5 mM-data not shown) establishing a role for LPA in neural development. Of note, rescue experiments were performed in the presence of bovine serum where LPA is present in high concentrations (Aoki, 2004; Tigyi and Miledi, 1992) but is most likely inactivated possibly due to binding to abundant albumin and/or gelsolin (Aoki, 2004; Tigyi and Miledi, 1992; Xu et al., 2009) . Neural tube defects (NTDs), similar the ones observed in Enpp2
embryos, are found in a group of severe human congenital abnormalities resulting from the failure of neurulation (De Marco et al., 2006) . The process of neurulation requires mechanisms including the planar cell polarity pathway for the initiation of neural tube closure, relatively unexplored in vertebrates (Wang and Nathans, 2007) , and the sonic hedgehog (Shh) signalling pathway, which regulates dorsal ventral (D-V) patterning and neural plate bending (Cohen, 2003; Ho and Scott, 2002) . Shh is first expressed in the notochord and the floor plate of the neural tube, in close proximity with the site of ATX's first expression. However no differences in the expression of Shh, its receptor Ptc1 and various bona fide D-V patterning genes were observed at Enpp2 −/− E9.5 embryos (Fig. 5) . Therefore, neural defects were not due to aberrant D-V patterning in the absence of ATX/LPA but most likely due to the absence of the LPA-mediated proliferation and cell death inhibition. Moreover and as well known, embryonic development and organogenesis are highly dependent on coordinated migration of different lineages over short and long distances throughout the body, while a large number of null mutants leading to embryonic lethality have direct effects on cytoskeletal dynamics and cell migration (Kurosaka and Kashina, 2008) . Early embryonic migration in particular is dominated by cells of the neural crest lineage that are classified into several types based on their origin and destination (Tucker, 2004) . Abnormal neural crest cell (NCC) migration in n-cofilin (Cfl1; an actin binding protein regulating cell migration (Bellenchi et al., 2007) ) null mutants was correlated with abnormal neural tube morphogenesis and embryonic lethality (Gurniak et al., 2005) . As LPA has been reported to modulate cofilin activity (Meberg et al., 1998) which has been implicated in regulating migration of various cells (Moolenaar et al., 2004) , and since absence of ATX leads to decreased steady-state levels of cofilin phosphorylation and actin polymerization (Koike et al., 2009) , it seems very likely that the absence of ATX/LPA would affect not only proliferation and apoptosis in the developing neural system but neural crest cell migration as well, affecting the development of various organs (including heart and vessels). Almost 200 mouse mutants with neural tube closure defects have been reported, whose functions cluster in pathways of actin function, apoptosis and chromatin methylation and structure (Harris and Juriloff, 2007) . Among them, only one was discovered deregulated in Fig. 6 . LPA stimulates embryo growth and rescues neurite outgrowth defect in the absence of ATX. wt and mutant embryo explants were cultured in vitro for 2 days in the presence or absence of LPA and immunostained for TUJ1 to detect neurite outgrowth. the absence of ATX/LPA with expression profiling: Hif-1a (with the highest negative fold change and among the most statistically significant). Embryonic HIF-1a expression was found severely compromised in the absence of ATX/LPA, correlating with increased cell death and diminished proliferation at the neural tube, independent of hypoxia levels (Fig. 7) . More importantly, LPA was shown to be able to restore HIF-1a expression in ATX null embryonic explants ex vivo (Fig. 7E) , as well as embryo size and neurite outgrowth (Fig. 6 ). Hif-1a −/− mouse mutants exhibit a very similar phenotype to Enpp2 −/− embryos (unlike LPA receptors null mutants (Choi et al., 2008) ): developmental arrest and lethality by E11, neural tube defects, aberrant yolk sac vascular branching morphogenesis, marked cell death within the cephalic mesenchyme, even enlarged vessels in the cephalic region (Iyer et al., 1998; Ryan et al., 1998) . Moreover, defective vascularization of Hif-1a null mutants was not associated with VEGF deficiency (as in the case of ATX null embryos) but with mesenchymal cell death (Kotch et al., 1999) . Although oxygen tension plays a major role in HIF-1a stabilization and activation, several growth factors, cytokines and oncogenes have been shown to induce HIF-1a expression under normoxia, most likely through the PI3K/Akt and MAPK signalling pathways (Bardos and Ashcroft, 2005; Semenza, 2007; Weidemann and Johnson, 2008) . Moreover, while Hif-1a activity is usually regulated at the protein level, basal NF-κB activity (that interestingly is known to be induced by LPA (Klemm et al., 2007) ) is required for the expression of enough mRNA at all times to result in the rapid accumulation of HIF-1a protein (Rius et al., 2008) , which occurs predominantly under hypoxia (which nevertheless also induces mRNA expression (Belaiba et al., 2007) ). Unpublished results from our lab indicate that TNF, the major pro-inflammatory cytokine, is able to induce Hif-1a mRNA expression in primary synovial fibroblasts, while LPA can induce HIF-1a expression in a smooth muscle cell line both at the mRNA and protein level (E. Paraskeva and G. Simos personal communication). A few reports have previously implicated LPA in hypoxia-dependent HIF-1a-mediated responses in vitro Lee et al., 2006; Park et al., 2007; Sako et al., 2006) . As shown here, ATX/LPA stimulate embryonic HIF-1a expression (most likely through PI3K/Akt signalling and/or NF-κB) independent of hypoxia levels, correlating with aberrant neural development. Conditional deletion of ATX in neuronal lineages would be necessary to further explore the suggested interrelationship between ATX/LPA, HIF-1a and the development of the nervous system. Additional experiments are also needed to establish if LPA can also stimulate HIF-1a expression in adult tissues and thus contribute directly or indirectly to various pathophysiological conditions including cancer, where HIF-1a is a major therapeutic target (Semenza, 2003) .
